WBH ADVISORY INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
WBH ADVISORY INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$212,000
-10.9%
1,9110.0%0.03%
-17.1%
Q4 2020$238,000
-3.6%
1,911
-11.2%
0.04%
-19.6%
Q4 2019$247,000
-11.5%
2,152
-2.7%
0.05%
-19.0%
Q3 2019$279,000
+3.3%
2,212
-1.7%
0.06%0.0%
Q2 2019$270,000
+14.4%
2,250
-4.7%
0.06%
+10.5%
Q4 2018$236,000
-12.6%
2,3600.0%0.06%
-12.3%
Q3 2018$270,000
+20.5%
2,360
-5.6%
0.06%
+12.1%
Q2 2018$224,0002,5000.06%
Other shareholders
HAEMONETICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders